1992
DOI: 10.1002/ardp.19923250915
|View full text |Cite
|
Sign up to set email alerts
|

Novel Benzo[b]thienylhydrazine and 1,3,4‐Oxadiazole Derivatives as Potential Antidepressant Agents

Abstract: Three novel series of benzo[b]thiophene derivatives bearing various hydrazone, hydrazine and 1,3,4-oxadiazole moieties were synthesized as potential antidepressant agents. 22 Compounds were evaluated for their in vitro inhibitory effect on monoamine oxidase enzyme (MAO) type A. Several compounds inhibited MAO stronger than pargyline hydrochloride. Maximum inhibitions of 83% and 90% were observed with 1-benzyl-2-(3-chlorobenzo[b]thienyl-2-carbonyl)hydrazine (24) and 1-[2-(4-chlorophenyl)ethyl]-2-(3-chlorobenzo[… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2000
2000
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 21 publications
0
5
0
Order By: Relevance
“…In the 13 C-NMR spectra of compounds 4a-g, the two carbon atoms from the oxadiazole ring appear at ca. 160 ppm for the one linked to the benzo[b]thiophene moiety and at ca.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…In the 13 C-NMR spectra of compounds 4a-g, the two carbon atoms from the oxadiazole ring appear at ca. 160 ppm for the one linked to the benzo[b]thiophene moiety and at ca.…”
Section: Resultsmentioning
confidence: 99%
“…The elemental analysis was performed on a COSTECH Instruments EAS32 apparatus. The NMR spectra were recorded on a Varian Gemini 300 BB instrument, operating at 300 MHz for 1 H and 75 MHz for 13 C, in DMSO-d 6 or CDCl 3 , using TMS as internal standard. Mass spectra were obtained on a Finnigan MAT 90 spectrometer using CI technique (150eV, isobutane).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Development of several techniques for the facile construction of the scaffold had captured acceleration . Over the last decade, approximately 686 patents have been filed on oxadiazole pharmacophore and its importance 2,5‐Disubstituted oxadiazole subsidiaries have been encompassed with promising pharmacological profiles such as anticancer, antitubercular, antimicrobial, antifungal, antiepileptic, analgesic, antitumour, ulcerogenic, hypoglycaemic, central nervous system, antidepressant, hypnotic and sedative properties . Few compounds viz., zibotentan, ataluren, and raltegravir (Figure ) comprising oxadiazole as core nucleus are in the late stages of clinical trials substantiating the valuable privileges of the scaffold.…”
Section: Introductionmentioning
confidence: 99%